EUVIMEDEUVIMED entdecken
Crossref

Salvianolic acid A ameliorates sepsis through inhibiting inflammation via binding STING and modulating TBK1/IRF3 signaling pathway

Xiangying Qin, Liyuan Zhang, Jiahui Tang, Fan Zhang, Ling Zhang, Meng Yue, Shihui Yu, Shuaishuai Gong, Fang Li, Boyang Yu, Junping Kou, Yuanyuan Zhang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xiangying Qin und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese…. Hauptthemen laut MEDLINE: Sepsis, Interferon Regulatory Factor-3, Protein Serine-Threonine Kinases, Caffeic Acids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, China Pharmaceutical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a condition characterized by a systemic inflammatory response due to infection, resulting in numerous organ dysfunction. Salvianolic acid A (SAA) is a phenolic acid substance extracted from the plant Salvia miltiorrhiza Bunge, possessing antioxidant and anti-platelet aggregation properties. Although aberrant stimulator of interferon genes (STING) signaling is associated with sepsis, it is uncertain if SAA can influence this pathway to avert sepsis-induced organ injury. This study examined the antiseptic efficacy and biological mechanisms of SAA. The pharmacodynamics and mechanism of action of SAA in countering STING-induced inflammation during sepsis were investigated utilizing a cecal ligation and puncture (CLP) sepsis animal model. In vitro, RAW264.7 and THP-1 cells were preincubated with SAA for one hour before exposure to lipopolysaccharide (LPS). The molecular mechanism of SAA in the treatment of sepsis was examined by biochemical assays, pathological sections, enzyme-linked immunosorbent assay (ELISA), and western blot analysis. The association between SAA and its targets was examined via cellular thermal shift assay (CETSA), molecular docking, and molecular dynamics simulation analysis. The SAA intervention enhanced the survival rate of mice (18.75 % in the model group versus 55 % in the high-dose group) and dramatically reduced neutrophil infiltration in lung tissue as well as histological changes. It enhanced hepatorenal function and reduced inflammatory cytokines. Furthermore, the in vivo findings demonstrated that SAA could suppress the activation of the STING and TBK1/IRF3 signaling pathway, corroborating the in vitro results. SAA directly interacts with STING and regulates the TBK1/IRF3 signaling pathway to mitigate organ damage and inflammation caused by sepsis. It may serve as a viable therapeutic agent and prospective STING inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisInterferon Regulatory Factor-3Protein Serine-Threonine KinasesCaffeic AcidsMembrane ProteinsAnti-Inflammatory AgentsLactatesAnimalsMiceSignal TransductionHumansRAW 264.7 CellsMaleMice, Inbred C57BLDisease Models, AnimalTHP-1 CellsLipopolysaccharidesCytokinesSTING Protein

Stichwörter der Autor:innen

InflammationSTINGSalvianolic acid ASepsis

Substanzen

Interferon Regulatory Factor-3Protein Serine-Threonine KinasesCaffeic AcidsMembrane ProteinsAnti-Inflammatory AgentsLactatesLipopolysaccharidesCytokinessalvianolic acid ATbk1 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmac…

Förderung

  • Natural Science Foundation of Jiangsu Province
  • China Pharmaceutical University
  • National Natural Science Foundation of China

Zitieren

APA

Qin, X., Zhang, L., Tang, J., Zhang, F., Zhang, L., Yue, M., Yu, S., Gong, S., Li, F., Yu, B., Kou, J., & Zhang, Y. (2025). Salvianolic acid A ameliorates sepsis through inhibiting inflammation via binding STING and modulating TBK1/IRF3 signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115104

Vancouver

Qin X, Zhang L, Tang J, Zhang F, Zhang L, Yue M, et al. Salvianolic acid A ameliorates sepsis through inhibiting inflammation via binding STING and modulating TBK1/IRF3 signaling pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115104

BibTeX
@article{Qin2025,
  author = {Qin, Xiangying and Zhang, Liyuan and Tang, Jiahui and Zhang, Fan and Zhang, Ling and Yue, Meng and Yu, Shihui and Gong, Shuaishuai and Li, Fang and Yu, Boyang and Kou, Junping and Zhang, Yuanyuan},
  title = {Salvianolic acid A ameliorates sepsis through inhibiting inflammation via binding STING and modulating TBK1/IRF3 signaling pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115104}
}
Kostenlos starten →